Journal
TRANSPLANTATION
Volume 87, Issue 9, Pages S49-S53Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e3181a28635
Keywords
Mesenchymal stem cells; GMP; Clinical grade culture
Categories
Ask authors/readers for more resources
Mesenchymal stem cells (MSC) are multipotent adult stein cells harboring a wide range of differentiations and nonhuman leukocyte antigen-restricted immunosuppressive properties that lead to an increasing use of MSC in immuno-modulation and in regenerative medicine. To produce MSC, definitive standards are still lacking. Whatever the starting material used (e.g., bone marrow, adipose tissue, or cord blood), numerous parameters including cell plating density, number of passages, and culture medium, play a major role in the culture process and have to be determined. To date, the different production processes have been effective, and based on phenotypic analysis and differentiation potential, a first set of simple controls have been defined. However, controls of the final product should provide precise data on efficacy and safety. The next challenge will be to develop production processes that reach good manufacturing practices goals and to define more accurate control methods of cultivated MSC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available